A
A
A

Local websites

Businesses

Other websites

General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

More information

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44
investor.relations@novartis.com

More information

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999
eric.althoff@novartis.com

More information

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Print
PDF

Company information

Fact sheet

Find key company information in the Novartis fact sheet. The fact sheet is also available for download. »
Leadership

Read biographies of the Novartis Executive Committee (ECN) and other members of our senior management. »
Clinical pipeline

View the planned filings in our clinical pipeline. »
Acquisitions and divestments

Learn about how Novartis has been transformed into a leader focused on fast-growing areas of healthcare. »
Corporate citizenship

Through responsible business, we endeavor to create value for society. Learn about Corporate citizenship at Novartis. »
Company history

Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz. Take an interactive tour of our company history. »

Top links

Top downloads

Stock chart

Stock performance

Q1 results 2013

Novartis announced its results for the first quarter of 2013 on April 24 ›

Novartis country websites:

Novartis business websites:

Worldwide offices

Select an office Select an office

Follow us

Novartis on Flickr

Stay up-to-date

© 2013 Novartis AG Terms of use Privacy policy Sitemap